Glenview Trust’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Glenview Trust’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.39M	Buy	174,361 +33,298	+24%	+$839K	0.06%	170
2026 Q1	$3.56M	Buy	141,063 +47,800	+51%	+$1.22M	0.06%	184
2025 Q4	$2.38M	Buy	93,263 +42,177	+83%	+$1.08M	0.04%	211
2025 Q3	$1.31M	Buy	51,086 +30,552	+149%	+$775K	0.02%	261
2025 Q2	$519K	Buy	20,534 +8,400	+69%	+$208K	0.01%	369
2025 Q1	$303K	Buy	+12,134	New	+$300K	0.01%	409

Other funds holding IBDX

ACA

Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

Glenview Trust's IBDX Position: Q2 2026 in Review

Glenview Trust increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 24% in Q2 2026, buying an estimated $839K and bringing the position to 174,361 shares worth $4.39M. The position accounts for 0.06% of the portfolio, ranked #170.

Glenview Trust first reported a position in IBDX in Q1 2025 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

Glenview Trust held 174,361 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $4.39M as of Q2 2026.
Glenview Trust bought 33,298 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $839K.
iShares iBonds Dec 2032 Term Corporate ETF made up 0.06% of Glenview Trust's portfolio in Q2 2026, its #170 holding.
Glenview Trust first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2025 and has held it in 6 quarters since.
228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.